Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2010
12/23/2010WO2010090756A3 Fret-assays, methods for performing the assays and compounds relevant to the assays
12/23/2010WO2010067339A3 Fusion protein capable of binding vegf-a and tnf-alpha
12/23/2010WO2010034718A8 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
12/23/2010WO2010023195A3 Compositions and methods for treating cancer
12/23/2010WO2009097394A3 Methods for modulating a population of myeloid-derived suppressor cells and uses thereof
12/23/2010US20100324564 Particles, grains or granules for the treatment of an injured vertebra
12/23/2010US20100323975 Therapeutic agent for cerebral ischemic injury
12/23/2010US20100323974 Inhibitors of PARP Activity and Uses Thereof
12/23/2010US20100323973 Conjugates containing hydrophilic spacer linkers
12/23/2010US20100323972 Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy
12/23/2010US20100323971 Cell permeable nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same
12/23/2010US20100323970 Sap variants and their use
12/23/2010US20100323969 Compounds Binding to P-Selectin
12/23/2010US20100323968 Process of inhibiting cell death in injured cartilage
12/23/2010US20100323967 RNA Antagonist Compounds for the Modulation of MCL-1
12/23/2010US20100323966 FVIII Peptides and Their Use in Tolerising Haemophiliacs
12/23/2010US20100323965 Thrombopoietin Mimetics
12/23/2010US20100323964 New non-selective somatostatin analogues
12/23/2010US20100323963 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
12/23/2010US20100323962 Method of Reduction of Wrinkles on Skin, Darkening of Hair and Acceleration of Wound Healing by Applying Peptides Related to Basic Fibroblast Growth Factor (bFGF)
12/23/2010US20100323961 Surface eroding sutures
12/23/2010US20100323960 Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial
12/23/2010US20100323959 Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial
12/23/2010US20100323958 Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial
12/23/2010US20100323957 Novel assay for inhibitors of egfr
12/23/2010US20100323956 Glucose-regulating polypeptides and methods of making and using same
12/23/2010US20100323955 Methods for treating obesity and obesity related diseases and disorders
12/23/2010US20100323954 Chimeric polypeptides and uses thereof
12/23/2010US20100323953 Macrocyclic hepatitis c protease inhibitors
12/23/2010US20100323952 Nucleoside Analogs in Combination Therapy of Herpes Simplex Infections
12/23/2010US20100323951 Antibacterial peptides active in systemic infections
12/23/2010US20100323950 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer
12/23/2010US20100323949 erythropoietin mimetic peptide derivative and its pharmaceutical salts, the preparation and uses thereof
12/23/2010US20100323423 PEG-Urate Oxidase Conjugates and Use Thereof
12/23/2010US20100323422 PEG-Urate Oxidase Conjugates and Use Thereof
12/23/2010US20100323420 Regulated apoptosis
12/23/2010US20100323351 Tumor suppressor gene, p47ing3
12/23/2010US20100323033 Cancer sensitizer comprising chlorogenic acid
12/23/2010US20100323030 Composition with Anti-Inflammatory, Protein Synthesizing, Enzyme Deficiency Activating Genetic Therapy and Anti-Cancer Activity and Methods of Use
12/23/2010US20100323029 Five-coordinate neuroglobin and use thereof as a blood substitute
12/23/2010US20100323021 Antitumoral treatments
12/23/2010US20100323019 Microparticles for the treatment of disease
12/23/2010US20100323003 Flaviviridae Mutants Comprising a Deletion in the Capsid Protein for Use as Vaccines
12/23/2010US20100323002 Inhibition of melanogenesis and melanoma metastasis with p-amino benzoic acid (paba)
12/23/2010US20100322998 Skin ulcer preventive curative agent containing human recombinant hgf
12/23/2010US20100322993 Injectable biocompatible composition
12/23/2010US20100322977 Biomaterials, compositions, and methods
12/23/2010US20100322974 Targeting the histone code as a bacterial strategy for selectively modulating gene expression
12/23/2010US20100322958 Modified saccharides
12/23/2010US20100322955 Virulence genes, proteins, and their use
12/23/2010US20100322953 Lipidated Tumor-Associated Antigens and Immunotherapeutic Compositions
12/23/2010US20100322949 Methods for diagnosing and treating astrocytomas
12/23/2010US20100322948 Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same
12/23/2010US20100322942 Therapeutic and prophylactic methods for neuromuscular disorders
12/23/2010US20100322940 In vitro modification of glycosylation patterns of recombinant glycopeptides
12/23/2010US20100322936 Lm-1 antibodies, functional fragments, lm-1 target antigen, and methods for making and using same
12/23/2010US20100322932 Methods for amyloid removal using anti-amyloid antibodies
12/23/2010US20100322930 Fibronectin-based binding molecules and their use
12/23/2010US20100322928 Methods of diagnosing, monitoring treatment and treating systemic lupus erythematosus (sle)
12/23/2010US20100322926 Methods of using cadherin 11 (cdh11) antagonists
12/23/2010US20100322925 Alk7 and myostatin inhibitors and uses thereof
12/23/2010US20100322918 Diffusion enhancing compounds and their use alone or with thrombolytics
12/23/2010US20100322917 Pharmaceutical composition containing arazyme for the prevention of liver dysfunction
12/23/2010US20100322916 Dna repair polypeptides and methods of delivery and use
12/23/2010US20100322915 Protease Variants for Pharmaceutical Use
12/23/2010US20100322914 Prodrug anti-cancer therapy
12/23/2010US20100322913 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
12/23/2010US20100322912 Combination Enzyme Therapy for Gastric Digestion of Dietary Gluten in Celiac Sprue Patients
12/23/2010US20100322908 Compositions and methods for augmentation and regeneration of living tissue in a subject
12/23/2010US20100322907 Expansion of Hematopoietic Stem Cells
12/23/2010US20100322902 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle
12/23/2010US20100322901 5, 6-ring annulated indole derivatives and use thereof
12/23/2010US20100322900 Treatment of multiple sclerosis with laquinimod
12/23/2010US20100322899 Methods of improving central nervous system functioning
12/23/2010US20100322898 Methods of treating cancer using il-21
12/23/2010US20100322897 Characterization of il-17f and il-17r interactions
12/23/2010US20100322896 Molecular adjuvant
12/23/2010US20100322895 T cell depleting compositions useful for treating cancer
12/23/2010US20100322894 Combination Therapies for Treating Type 1 Diabetes
12/23/2010US20100322893 Ctla-4 protein variants
12/23/2010US20100322874 Absorbant/compliant solution-free cleaning and multiactive compositions
12/23/2010US20100322872 Novel methods and medicament for treating infectious diseases involving microbial biofilms
12/23/2010US20100322862 Methods and compositions using peptides and proteins with c-terminal elements
12/23/2010US20100322856 Compositions and Methods for Inducing Angiogenesis
12/23/2010US20100322853 Nanoparticulate compositions of angiogenesis inhibitors
12/23/2010US20100322852 Nanoparticulate compositions of angiogenesis inhibitors
12/23/2010DE102009030351A1 Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen A composition for treatment of degenerative joint diseases
12/23/2010DE102009025119A1 Herstellung und Verwendung antitumoraler, antibiotischer und insektizider Cyclodepsipeptide Production and use of antitumor, antimicrobial and insecticidal cyclodepsipeptides
12/23/2010CA2776883A1 Antimicrobial and antibiofilm activity of cathelicidins
12/23/2010CA2765792A1 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
12/23/2010CA2765688A1 Protease variants
12/23/2010CA2765657A1 Anti-gram-negative bacteria agent
12/23/2010CA2765541A1 Nanodispersion of a drug and process for its preparation
12/23/2010CA2765423A1 Casein derived protease inhibitory peptides
12/23/2010CA2765394A1 Sap variants and their use
12/23/2010CA2765345A1 Peptide therapy for increasing platelet levels
12/23/2010CA2765221A1 Safe desmopressin administration
12/23/2010CA2765026A1 Gip receptor-active glucagon compounds
12/22/2010EP2264176A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/22/2010EP2264175A1 Fibroblast growth factor homologs
1 ... 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 ... 3163